Stay updated on GTX-102 Safety in Angelman Syndrome Kids Clinical Trial
Sign up to get notified when there's something new on the GTX-102 Safety in Angelman Syndrome Kids Clinical Trial page.

Latest updates to the GTX-102 Safety in Angelman Syndrome Kids Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedRevision v3.4.3 was added to the history, replacing v3.4.2.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedThe record history shows a new revision entry (v3.4.2) and the deletion of the previous revision entry (v3.4.1). This updates the audit trail displayed on the page but does not change study details or core content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check39 days agoChange DetectedThe page history shows only a minor update to the revision list (v3.4.1 added and v3.4.0 removed). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check46 days agoChange DetectedThe UI adds a glossary toggle, shows color-coded additions (green) and deletions (red), and updates the revision label to v3.4.0 with a capitalization change for 'No FEAR Act Data'.SummaryDifference0.6%

- Check61 days agoChange DetectedNew version 44 (2026-01-09, Revision v3.3.4) adds updates to Contacts/Locations, Oversight, Study Status, and Study Identification. The prior version (2025-01-31, Revision v3.3.3) appears to be superseded.SummaryDifference0.5%

- Check82 days agoChange DetectedRevision: v3.3.3 was added to the page footer, and 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2' were removed.SummaryDifference0.1%

Stay in the know with updates to GTX-102 Safety in Angelman Syndrome Kids Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GTX-102 Safety in Angelman Syndrome Kids Clinical Trial page.